Until recently, taking a GLP-1 for weight loss meant weekly injections. But that changed in late 2025 with oral Wegovy® (semaglutide), the first FDA-approved GLP-1 pill for weight management. Shortly after, Foundayo® (orforglipron), a nonpeptide alternative with fewer timing and dietary restrictions, received approval.

While both medications can help with weight loss, key differences in dosing schedules, drug interactions, and clinical data set them apart. Below, we’ll look at Foundayo® versus Wegovy® to help you navigate your options and discuss the best fit with your provider.

‍

How GLP-1s work

After you eat, your small intestine and colon naturally release glucagon-like peptide-1 (GLP-1). This hormone:

• Slows gastric emptying: Binds to vagus nerve receptors in the stomach, sending signals to decrease muscle contractions and keep food in your stomach for longer
• Signals fullness: Crosses the blood-brain barrier to reach your appetite regulation center (hypothalamus), signaling feelings of fullness that reduce food intake
• Regulates insulin: Prompts the pancreas to release insulin after a meal so your cells can absorb and use post-meal blood sugar for energy
• Suppresses glucagon: Blocks the release of glucagon, preventing your liver from dumping unnecessary extra sugar into your bloodstream while you digest

GLP-1 medications like Foundayo® (orforglipron) and Wegovy® (semaglutide) attach to GLP-1 receptors throughout the body to set off these effects. As a result, you feel full sooner for longer, so you eat less overall and gradually lose weight.

‍

GLP-1 pill comparison: Wegovy® vs. Foundayo®

Although they use the same mechanism, semaglutide and orforglipron molecules have completely different structures:

• Semaglutide (Wegovy®) is a protein-like peptide that stomach acids and enzymes can easily break down. Even with an absorption aid, your bloodstream takes in only 1% to 2% of each Wegovy® pill. Food and water trigger extra digestive juices, lowering absorption even further. To maximize its effect, take Wegovy® on an empty stomach with no more than four ounces of plain water. Wait 30 minutes before eating food, drinking anything else like water or coffee, and taking any other oral medications.
• Orforglipron (Foundayo®) uses a simpler nonpeptide molecule that’s less than a quarter the size of semaglutide. This molecule can slip past stomach enzymes undetected. Your body absorbs roughly 77% of each dose, regardless of food or drink. For this reason, you can take Foundayo® any time of the day.

Here’s a comparison of Wegovy® versus Foundayo® at a glance:

‍

Foundayo® vs. Wegovy®: Efficacy for weight loss

No head-to-head clinical trials directly compare the Wegovy® pill and Foundayo® for weight loss. Their respective manufacturers—Eli Lilly and Novo Nordisk—tested them in separate trials with different populations and study lengths, making direct comparison difficult. Furthermore, factors like dose, consistency, and diabetes status can impact individual results. Still, it helps to know how much people tend to lose on average before choosing either of these drugs for your weight loss journey.

Here are the findings from those trials:

• Foundayo®: In the ATTAIN-1 trial, more than 3,000 adults took orforglipron or a placebo for 72 weeks. People on the highest dose, equivalent to Foundayo®’s 17.2 mg tablet, lost an average of 11.2% of their body weight compared with 2.1% on placebo.
• Wegovy®: OASIS 4 followed 307 adults taking oral semaglutide for 64 weeks. People taking the top dose, 25 mg, lost an average of 13.6% of their body weight, compared with 2.2% of those on placebo.

Wegovy® vs. Foundayo®: Side effects and safety

GLP-1s slow how quickly food leaves your stomach. That’s part of how they help with weight loss, but it’s also behind many of their side effects. Most are digestive, peak in the first weeks of treatment and after each dose increase, then ease as your body adjusts. The table below compares the percentage of clinical trial participants who reported each side effect while taking the highest standard doses of Wegovy® and Foundayo®:

‍

*Wegovy®’s data comes from the injection’s trials. According to the Wegovy® pill’s FDA label, common side effects were similar in type and frequency. 

Boxed warnings

Both Wegovy® and Foundayo® carry a boxed warning for thyroid C-cell tumors. Early rodent studies showed an increased risk of thyroid tumors, though it’s unknown whether these findings apply to humans. As a precaution, don’t take either medication if you or a family member have a history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia type 2 (MEN 2).

Serious risks

Beyond the boxed warning, both drug labels list additional serious—though less common—risks:

• Pancreatitis: Inflammation of the pancreas, including severe, persistent stomach pain that radiates to your back, with or without vomiting
• Gallbladder disease: Gallstones or gallbladder inflammation, including sharp pain in the upper-right abdomen, fever, jaundice, or clay-colored stools
• Acute kidney injury: Kidney damage caused by dehydration from gastrointestinal side effects like persistent vomiting or diarrhea

Seek immediate medical care if you experience any of these symptoms.

‍

Foundayo® vs. Wegovy®: Cost and coverage

Out-of-pocket prices for both medications are comparable when purchased through manufacturer programs like LillyDirect and NovoCare. Monthly self-pay costs range from $149 to $299 for the Wegovy® pill and $149 to $349 for Foundayo®, depending on the required dose.

With commercial insurance, manufacturer savings cards for both medications reduce copays to as little as $25 a month, capped at $100 in savings with plan coverage. However, according to a 2026 survey by the International Foundation of Employee Benefit Plans, only about one-third of employers currently cover GLP-1s for weight loss, and most enforce strict eligibility requirements.

Alternatively, eligible Medicare Part D members can receive either pill for $50 a month through December 31, 2027 under the temporary Medicare GLP-1 Bridge Program.

Who should use Wegovy® vs. Foundayo®?

There’s no single best GLP-1 pill for weight loss, only the best fit for you based on your habits, health history, and pregnancy plans. Here are some factors that may help with your decision:

*Nonoral birth control options like IUDs, patches, or rings bypass stomach absorption and aren’t expected to be affected.

‍

Find the right GLP-1 treatment for you with Maven Clinic

While both GLP-1s effectively help with weight loss, the right choice for you depends on your specific lifestyle and medical needs. The Wegovy® pill requires a stricter morning routine but carries a lower risk of drug interactions. Foundayo® offers anytime dosing but requires careful checking of existing prescriptions and birth control methods.

Maven Clinic’s GLP-1 Care connects you with specialists who consider your full clinical picture, goals, and lifestyle to find the best treatment for you. From treatment selection and ongoing side-effect management to exercise guidance and nutrition support, we help you achieve sustainable results.